skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Identification of metabolic signatures linked to anti-inflammatory effects of Faecalibacterium prausnitzii

Abstract

Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified on the basis of human clinical data. The mechanisms underlying its beneficial effects are still unknown. Gnotobiotic mice harboring F. prausnitzii (A2-165) and Escherichia coli (K-12 JM105) were subjected to 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced acute colitis. The inflammatory colitis scores and a gas chromatography-time of flight (GC/TOF) mass spectrometry-based metabolomic profile were monitored in blood, ileum, cecum, colon, and feces in gnotobiotic mice. The potential anti-inflammatory metabolites were tested in vitro. We obtained stable E. coli and F. prausnitzii-diassociated mice in which E. coli primed the gastrointestinal tract (GIT), allowing a durable and stable establishment of F. prausnitzii. The disease activity index, histological scores, myeloperoxidase (MPO) activity, and serum cytokine levels were significantly lower in the presence of F. prausnitzii after TNBS challenge. The protective effect of F. prausnitzii against colitis was correlated to its implantation level and was linked to overrepresented metabolites along the GIT and in serum. Among 983 metabolites in GIT samples and serum, 279 were assigned to known chemical reactions. Some of them, belonging to the ammonia (α-ketoglutarate), osmoprotective (raffinose), and phenolic (including anti-inflammatory shikimic and salicylic acids) pathways, were associated with a protective effect of F. prausnitzii, andmore » the functional link was established in vitro for salicylic acid. We show for the first time that F. prausnitzii is a highly active commensal bacterium involved in reduction of colitis through in vivo modulation of metabolites along the GIT and in the peripheral blood.« less

Authors:
 [1];  [2];  [1];  [1];  [1];  [2];  [1];  [1];  [3];  [3];  [1];  [4];  [1];  [1]
  1. Commensal and Probiotics-Host Interactions Lab., Jouy-en-Josas (France); AgroParisTech, Jouy-en-Josas (France)
  2. AgroParisTech, Jouy-en-Josas (France); Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States)
  3. Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States)
  4. Commensal and Probiotics-Host Interactions Lab., Jouy-en-Josas (France); AgroParisTech, Jouy-en-Josas (France); Univ. Pierre et Marie Curie (UPMC), Paris (France); Hopital Saint-Antoine, Assistance Publique-Hopitaux de Paris, Paris (France)
Publication Date:
Research Org.:
Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States)
Sponsoring Org.:
USDOE Office of Science (SC)
OSTI Identifier:
1215663
Grant/Contract Number:  
AC02-05CH11231
Resource Type:
Journal Article: Accepted Manuscript
Journal Name:
mBio (Online)
Additional Journal Information:
Journal Volume: 6; Journal Issue: 2; Journal ID: ISSN 2150-7511
Publisher:
American Society for Microbiology
Country of Publication:
United States
Language:
English
Subject:
59 BASIC BIOLOGICAL SCIENCES

Citation Formats

Miquel, Sylvie, Leclerc, Marion, Martin, Rebeca, Chain, Florian, Lenoir, Marion, Raguideau, Sébastien, Hudault, Sylvie, Bridonneau, Chantal, Northen, Trent, Bowen, Benjamin, Bermúdez-Humarán, Luis G., Sokol, Harry, Thomas, Muriel, and Langella, Philippe. Identification of metabolic signatures linked to anti-inflammatory effects of Faecalibacterium prausnitzii. United States: N. p., 2015. Web. doi:10.1128/mBio.00300-15.
Miquel, Sylvie, Leclerc, Marion, Martin, Rebeca, Chain, Florian, Lenoir, Marion, Raguideau, Sébastien, Hudault, Sylvie, Bridonneau, Chantal, Northen, Trent, Bowen, Benjamin, Bermúdez-Humarán, Luis G., Sokol, Harry, Thomas, Muriel, & Langella, Philippe. Identification of metabolic signatures linked to anti-inflammatory effects of Faecalibacterium prausnitzii. United States. https://doi.org/10.1128/mBio.00300-15
Miquel, Sylvie, Leclerc, Marion, Martin, Rebeca, Chain, Florian, Lenoir, Marion, Raguideau, Sébastien, Hudault, Sylvie, Bridonneau, Chantal, Northen, Trent, Bowen, Benjamin, Bermúdez-Humarán, Luis G., Sokol, Harry, Thomas, Muriel, and Langella, Philippe. 2015. "Identification of metabolic signatures linked to anti-inflammatory effects of Faecalibacterium prausnitzii". United States. https://doi.org/10.1128/mBio.00300-15. https://www.osti.gov/servlets/purl/1215663.
@article{osti_1215663,
title = {Identification of metabolic signatures linked to anti-inflammatory effects of Faecalibacterium prausnitzii},
author = {Miquel, Sylvie and Leclerc, Marion and Martin, Rebeca and Chain, Florian and Lenoir, Marion and Raguideau, Sébastien and Hudault, Sylvie and Bridonneau, Chantal and Northen, Trent and Bowen, Benjamin and Bermúdez-Humarán, Luis G. and Sokol, Harry and Thomas, Muriel and Langella, Philippe},
abstractNote = {Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified on the basis of human clinical data. The mechanisms underlying its beneficial effects are still unknown. Gnotobiotic mice harboring F. prausnitzii (A2-165) and Escherichia coli (K-12 JM105) were subjected to 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced acute colitis. The inflammatory colitis scores and a gas chromatography-time of flight (GC/TOF) mass spectrometry-based metabolomic profile were monitored in blood, ileum, cecum, colon, and feces in gnotobiotic mice. The potential anti-inflammatory metabolites were tested in vitro. We obtained stable E. coli and F. prausnitzii-diassociated mice in which E. coli primed the gastrointestinal tract (GIT), allowing a durable and stable establishment of F. prausnitzii. The disease activity index, histological scores, myeloperoxidase (MPO) activity, and serum cytokine levels were significantly lower in the presence of F. prausnitzii after TNBS challenge. The protective effect of F. prausnitzii against colitis was correlated to its implantation level and was linked to overrepresented metabolites along the GIT and in serum. Among 983 metabolites in GIT samples and serum, 279 were assigned to known chemical reactions. Some of them, belonging to the ammonia (α-ketoglutarate), osmoprotective (raffinose), and phenolic (including anti-inflammatory shikimic and salicylic acids) pathways, were associated with a protective effect of F. prausnitzii, and the functional link was established in vitro for salicylic acid. We show for the first time that F. prausnitzii is a highly active commensal bacterium involved in reduction of colitis through in vivo modulation of metabolites along the GIT and in the peripheral blood.},
doi = {10.1128/mBio.00300-15},
url = {https://www.osti.gov/biblio/1215663}, journal = {mBio (Online)},
issn = {2150-7511},
number = 2,
volume = 6,
place = {United States},
year = {Tue Apr 21 00:00:00 EDT 2015},
month = {Tue Apr 21 00:00:00 EDT 2015}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record

Citation Metrics:
Cited by: 164 works
Citation information provided by
Web of Science

Save / Share:

Works referenced in this record:

Grifola frondosa water extract alleviates intestinal inflammation by suppressing TNF-α production and its signaling
journal, January 2010


Shikimic acid: review of its analytical, isolation, and purification techniques from plant and microbial sources
journal, July 2011


Biosynthesis of 5-Aminopentanoic Acid and 2-Piperidone from Cadaverine and 1-Piperideine in Mouse
journal, December 1984


Butyrate modulates intestinal epithelial cell-mediated neutrophil migration
journal, January 2003


Measurement of Cutaneous Inflammation: Estimation of Neutrophil Content with an Enzyme Marker
journal, March 1982


Ecology and metabolism of the beneficial intestinal commensal bacterium Faecalibacterium prausnitzii
journal, January 2014


Fermentation in the Human Large Intestine: Its Physiologic Consequences and the Potential Contribution of Prebiotics
journal, January 2011


A human gut microbial gene catalogue established by metagenomic sequencing
journal, March 2010


Faecalibacterium prausnitzii supernatant improves intestinal barrier function in mice DSS colitis
journal, August 2013


The role of pH in determining the species composition of the human colonic microbiota
journal, August 2009


Low counts of Faecalibacterium prausnitzii in colitis microbiota
journal, January 2009


Chemical evolution of the citric acid cycle: Sunlight photolysis of α-ketoglutaric acid
journal, June 1987


Numerical ecology validates a biogeographical distribution and gender-based effect on mucosa-associated bacteria along the human colon
journal, December 2010


Faecalibacterium prausnitzii and human intestinal health
journal, June 2013


Ameliorative effects of 3,4-oxo-isopropylidene-shikimic acid on experimental colitis and their mechanisms in rats
journal, March 2013


Dysbiosis in inflammatory bowel diseases: the oxygen hypothesis
journal, May 2013


Butyrate Switches the Pattern of Chemokine Secretion by Intestinal Epithelial Cells through Histone Acetylation
journal, September 1999


Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites
journal, February 2009


Immunomodulatory action of spermine and spermidine on NR8383 macrophage line in various culture conditions
journal, December 2003


Role of commensal and probiotic bacteria in human health: a focus on inflammatory bowel disease
journal, January 2013


The gut microbiota modulates host energy and lipid metabolism in mice
journal, December 2009


Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients
journal, October 2008


Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease
journal, January 1989


Active Crohnʼs disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora
journal, January 2008


Primocolonization is associated with colonic epithelial maturation during conventionalization
journal, February 2013


Characterisation of intestinal bacteria in infant stools using real-time PCR and northern hybridisation analyses
journal, September 2005


Anti-inflammatory effects of Lactobacillus casei BL23 producing or not a manganese-dependant catalase on DSS-induced colitis in mice
journal, January 2007


Mechanisms of homocysteine toxicity in humans
journal, February 2007


Vicious circles in inflammatory bowel disease
journal, January 2006


Metabolite profiling for plant functional genomics
journal, November 2000


Identification of One Novel Candidate Probiotic Lactobacillus plantarum Strain Active against Influenza Virus Infection in Mice by a Large-Scale Screening
journal, December 2012


Drastic changes in fecal and mucosa-associated microbiota in adult patients with short bowel syndrome
journal, July 2010


Symbiotic gut microbes modulate human metabolic phenotypes
journal, February 2008


Global and Deep Molecular Analysis of Microbiota Signatures in Fecal Samples From Patients With Irritable Bowel Syndrome
journal, November 2011


Mucosa-Associated Bacterial Diversity in Relation to Human Terminal Ileum and Colonic Biopsy Samples
journal, September 2007


The volatile compound BinBase mass spectral database
journal, January 2011


Microbial butyrate and its role for barrier function in the gastrointestinal tract: Butyrate and the gastrointestinal barrier
journal, June 2012


Microbial Dysbiosis in Colorectal Cancer (CRC) Patients
journal, January 2011


Low-Dose Ionizing Radiation-Induced Blood Plasma Metabolic Response in a Diverse Genetic Mouse Population
journal, December 2012


The Commensal Bacterium Faecalibacterium prausnitzii Is Protective in DNBS-induced Chronic Moderate and Severe Colitis Models
journal, January 2014


Effect of high-fiber and high-oil diets on the fecal flora of swine.
journal, January 1987


Functional analysis of colonic bacterial metabolism: relevant to health?
journal, January 2012


Butyrate modulates intestinal epithelial cell-mediated neutrophil migration
text, January 2003


Growth requirements and fermentation products of Fusobacterium prausnitzii, and a proposal to reclassify it as Faecalibacterium prausnitzii gen. nov., comb. nov.
journal, November 2002


Works referencing / citing this record:

Real friends: Faecalibacterium prausnitzii supports mucosal immune homeostasis
journal, November 2015


Signatures of early frailty in the gut microbiota
journal, January 2016


Impact of Dietary Resistant Starch on the Human Gut Microbiome, Metaproteome, and Metabolome
journal, October 2017


The significance of microbiome in personalized medicine
journal, May 2019


The Potential of Gut Commensals in Reinforcing Intestinal Barrier Function and Alleviating Inflammation
journal, July 2018


Evolving trends in next-generation probiotics: a 5W1H perspective
journal, May 2019


Faecalibacterium prausnitzii treatment improves hepatic health and reduces adipose tissue inflammation in high-fat fed mice
journal, April 2017


The microbiota shifts the iron sensing of intestinal cells
journal, September 2015


Xenobiotic Receptor-Mediated Regulation of Intestinal Barrier Function and Innate Immunity
journal, January 2016


Probiotics: a proactive approach to health. A symposium report
journal, November 2015


Modulation of Active Gut Microbiota by Lactobacillus rhamnosus GG in a Diet Induced Obesity Murine Model
journal, April 2018


Precision medicine using microbiota
journal, January 2018


Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics
journal, January 2017


Faecalibacterium prausnitzii and a Prebiotic Protect Intestinal Health in a Mouse Model of Antibiotic and Clostridium difficile Exposure
journal, January 2018


A Designer Synbiotic Attenuates Chronic-Binge Ethanol-Induced Gut-Liver Injury in Mice
journal, January 2019


Effect of cryopreservation and lyophilization on viability and growth of strict anaerobic human gut microbes
journal, April 2018


Diet, gut microbes, and the pathogenesis of inflammatory bowel diseases
journal, August 2016


Searching for the Bacterial Effector: The Example of the Multi-Skilled Commensal Bacterium Faecalibacterium prausnitzii
journal, March 2018


Mesenchymal stem cell–gut microbiota interaction in the repair of inflammatory bowel disease: an enhanced therapeutic effect
journal, December 2019


New insights into therapeutic strategies for gut microbiota modulation in inflammatory diseases
journal, June 2016


Microbiome–health interactions in older people
journal, October 2017


Bacteria isolated from lung modulate asthma susceptibility in mice
journal, January 2017


Paradigms of Lung Microbiota Functions in Health and Disease, Particularly, in Asthma
journal, August 2018


Microbiota dysbiosis in inflammatory bowel diseases: in silico investigation of the oxygen hypothesis
journal, December 2017


Effects of microbiota-directed foods in gnotobiotic animals and undernourished children
journal, July 2019


Gut microbiome alterations in patients with stage 4 hepatitis C
journal, September 2016


Rebuilding the Gut Microbiota Ecosystem
journal, August 2018